Daratumumab,Talquetamab,Teclistamab,Pomalidomide
janssen,genmab
['teclistamab', 'multiple myeloma', 'janssen']
janssen presents updated data at eha for teclistamab in patients with relapsed or refractory multiple myeloma #pharmanews #clinicalresearchnews #biotechnews #lifesciencesnews #medicalnews #healthcarenews #pharmiwebnews 
News from across the pharmaceutical and biotech industry from PharmiWeb https://t.co/ea1b58MZYg